FMP
AirSculpt Technologies, Inc.
AIRS
NASDAQ
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
1.8 USD
-0.26 (-14.44%)
Operating Data
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
62.77M
133.31M
168.79M
195.92M
180.35M
241.1M
322.31M
430.88M
576.01M
770.04M
Revenue %
-
112.4
26.61
16.07
-7.95
33.68
33.68
33.68
33.68
Ebitda
15.67M
23.05M
3.52M
19.74M
10.07M
28.93M
38.68M
51.71M
69.12M
92.41M
Ebitda %
24.97
17.29
2.08
10.07
5.58
12
12
12
12
Ebit
10.03M
16.45M
-4.54M
9.48M
-1.82M
14.21M
18.99M
25.39M
33.94M
45.38M
Ebit %
15.98
12.34
-2.69
4.84
-1.01
5.89
5.89
5.89
5.89
Depreciation
5.64M
6.6M
8.06M
10.25M
11.89M
14.72M
19.68M
26.31M
35.18M
47.03M
Depreciation %
8.99
4.95
4.78
5.23
6.59
6.11
6.11
6.11
6.11
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
10.38M
25.35M
9.62M
10.26M
8.23M
24.62M
32.91M
43.99M
58.81M
78.62M
Total Cash %
16.54
19.01
5.7
5.24
4.57
10.21
10.21
10.21
10.21
Receivables
-
-
2.83M
1.94M
-
1.29M
1.72M
2.3M
3.07M
4.11M
Receivables %
-
-
1.68
0.99
-
0.53
0.53
0.53
0.53
Inventories
-
-
-
-
-
-
-
-
-
-
Inventories %
-
-
-
-
-
-
-
-
-
Payable
1.09M
2.67M
3.84M
3.92M
6.26M
5.54M
7.41M
9.91M
13.24M
17.7M
Payable %
1.74
2
2.28
2
3.47
2.3
2.3
2.3
2.3
Cap Ex
-3.69M
-7.12M
-12.92M
-9.92M
-14.01M
-15.29M
-20.43M
-27.32M
-36.52M
-48.82M
Cap Ex %
-5.88
-5.34
-7.65
-5.06
-7.77
-6.34
-6.34
-6.34
-6.34
Weighted Average Cost Of Capital
Price
1.8
Beta
Diluted Shares Outstanding
57.69M
Costof Debt
18.06
Tax Rate
After Tax Cost Of Debt
18.06
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
34.6M
Total Equity
103.84M
Total Capital
138.44M
Debt Weighting
24.99
Equity Weighting
75.01
Wacc
13.43
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
62.77M
133.31M
168.79M
195.92M
180.35M
241.1M
322.31M
430.88M
576.01M
770.04M
Ebitda
15.67M
23.05M
3.52M
19.74M
10.07M
28.93M
38.68M
51.71M
69.12M
92.41M
Ebit
10.03M
16.45M
-4.54M
9.48M
-1.82M
14.21M
18.99M
25.39M
33.94M
45.38M
Tax Rate
-2.33
-2.33
-2.33
-2.33
-2.33
-2.33
-2.33
-2.33
-2.33
-2.33
Ebiat
7.61M
15.95M
-5.91M
-14.17M
-1.86M
10.6M
14.16M
18.94M
25.31M
33.84M
Depreciation
5.64M
6.6M
8.06M
10.25M
11.89M
14.72M
19.68M
26.31M
35.18M
47.03M
Receivables
-
-
2.83M
1.94M
-
1.29M
1.72M
2.3M
3.07M
4.11M
Inventories
-
-
-
-
-
-
-
-
-
-
Payable
1.09M
2.67M
3.84M
3.92M
6.26M
5.54M
7.41M
9.91M
13.24M
17.7M
Cap Ex
-3.69M
-7.12M
-12.92M
-9.92M
-14.01M
-15.29M
-20.43M
-27.32M
-36.52M
-48.82M
Ufcf
10.66M
17.01M
-12.42M
-12.87M
297.66k
8.03M
14.85M
19.85M
26.54M
35.47M
Wacc
13.43
13.43
13.43
13.43
13.43
Pv Ufcf
7.08M
11.54M
13.6M
16.03M
18.89M
Sum Pv Ufcf
67.14M
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
13.43
Free Cash Flow T1
36.18M
Terminal Value
316.53M
Present Terminal Value
168.56M
Intrinsic Value
Enterprise Value
235.71M
Net Debt
26.36M
Equity Value
209.34M
Diluted Shares Outstanding
57.69M
Equity Value Per Share
3.63
Projected DCF
3.63 0.504%
